Baycrest is unique in the world, combining a comprehensive system of care for aging patients, one of the world’s top research institutes in cognitive neuroscience, dedicated centres focused on mitigating the impact of age-related illness and impairment, and unmatched global knowledge exchange and commercialization capacity.
An independent benchmarking study concluded that few institutions match the breadth and uniqueness of the integrated models of service delivery and the calibre of translational research at Baycrest.
Baycrest has actively leveraged its remarkable complementary strengths in innovative care delivery and research by pursuing a unique commercialization agenda. It has partnered with MaRS Discovery District, a large-scale Toronto innovation centre, in the development of its first spinout company, Cogniciti. This company has been specifically established to create and bring to market products, goods, and services designed to maintain healthy cognitive functioning throughout middle adult and later years.
Baycrest is now launching a commercialization arm which will introduce a comprehensive and uniquely competitive portfolio of aging oriented products and goods, as well as consulting and development services to the international marketplace.
Baycrest is partnering with private and public sector organizations across Canada and around the world to advance healthy aging and the wellbeing of seniors. Already, Baycrest has alliances and partnerships across Canada exceeding 50 organizations and is engaged with nearly 60 additional collaborators across the globe.
Baycrest has been chosen to lead a Canadian and North American initiative with a goal of identifying promising new innovations in long-term senior care. Baycrest was also recently selected by Neurological Health Charities of Canada as a national award recipient for innovation and leadership in aging and brain health.
For more information please visit the website.